| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0a3c3dd767621e0cfe7c42a77ce9c0e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-001 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate |
2014-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ac7df0fd76bdb42f3575b7a1885bb9 |
| publicationDate |
2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015033086-A1 |
| titleOfInvention |
Dna construct |
| abstract |
A DNA construct comprising a hamster beta-actin promoter operably linked to a cytomegalovirus enhancer is provided. Preferably the promoter is Chinese hamster beta- actin promoter, and the enhancer is the hCMV Major Intermediate Early enhancer. The DNA constructs can be employed for the production of polypeptides of interest, especially antibodies and antibody fragments. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11618904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018000105-A1 |
| priorityDate |
2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |